Oral GLP1 Pill UK Medicines: What Is Available?
Not everyone feels comfortable with injections. For some people, taking a tablet each day may feel easier to fit into everyday life. The good news is that oral GLP1 medicines are now available in the UK for both weight management and type 2 diabetes.
For weight management, the UK currently has two licensed oral GLP1 medicines: Wegovy Pill (oral semaglutide) and Foundayo (orforglipron). There is also Rybelsus (oral semaglutide), which is licensed for the treatment of type 2 diabetes.
Although all three are tablets, they are not the same medicine. Wegovy Pill and Rybelsus contain semaglutide, while Foundayo contains orforglipron. They also have different instructions for taking them, which can make a real difference to your daily routine.
If you are considering an oral GLP1 medicine, it is worth looking beyond the fact that it comes as a tablet. Your medical history, the reason for treatment, the medicine's dosing instructions and what feels manageable for you all matter.
This guide explains what is currently available in the UK, how the medicines work, how they differ, what you need to know about taking them, and what happens if you are considering treatment through an online service.
Key things to know
- Wegovy Pill and Foundayo are licensed in the UK for weight management in eligible adults.
- Rybelsus is an oral semaglutide medicine licensed for type 2 diabetes.
- Wegovy Pill and Rybelsus need to be taken on an empty stomach with a small amount of water. You then need to wait at least 30 minutes before eating, drinking or taking other oral medicines.
- Foundayo can be taken once a day at any time, without specific food or water restrictions.
- These medicines are prescription only. A prescriber needs to assess whether treatment is suitable for you.
- Clinical trial results can help explain how medicines performed in studies, but they cannot predict exactly how much weight an individual person will lose.
What Oral GLP1 Medicines Are Currently Available in the UK?
| Medicine | Active Ingredient | Licensed For | Food/Water Requirement |
|---|---|---|---|
| Wegovy Pill | Semaglutide | Weight management | Empty stomach, small amount of water, then wait at least 30 minutes |
| Rybelsus | Semaglutide | Type 2 diabetes | Empty stomach, small amount of water, then wait at least 30 minutes |
| Foundayo | Orforglipron | Weight management and type 2 diabetes | No specific food or water restriction |
Wegovy Pill is licensed for weight management in adults with a BMI of 30 or above, or a BMI of 27 to below 30 where there is at least one weight related health condition.
Foundayo has similar BMI criteria for weight management and is also licensed for adults with insufficiently controlled type 2 diabetes.
Rybelsus is licensed for type 2 diabetes rather than weight management. Although it contains the same active ingredient as Wegovy Pill, that does not mean the two products can simply be used interchangeably.
Why Was Making a GLP1 Medicine Into a Tablet So Difficult?
A tablet may sound like the simpler option, but making a GLP1 medicine that can be taken by mouth is not straightforward.
Semaglutide is a peptide medicine. When taken by mouth, it has to pass through the digestive system before it can reach the bloodstream. The body naturally breaks down proteins and peptides during digestion, which can make absorption difficult.
The oral semaglutide formulation uses an absorption enhancer called salcaprozate sodium to help semaglutide get absorbed in the stomach. Even then, only a small proportion of the medicine is absorbed, which is why the way you take the tablet matters.
This also explains the strict instructions around food, water and other medicines. The amount of semaglutide absorbed can be lower if the tablet is taken with food or a large amount of water, or if other oral medicines are taken too soon afterwards.
Foundayo takes a different approach. Orforglipron is a small molecule rather than a peptide, and it is designed to activate the GLP1 receptor without relying on the same absorption enhancer used with oral semaglutide.
So, while both medicines act on the GLP1 receptor, they get there in different ways. That difference is reflected in their dosing instructions.
Two Different Approaches to an Oral GLP1 Medicine
Oral semaglutide: why the morning routine matters
Wegovy Pill and Rybelsus contain semaglutide and use an absorption enhancer to help the medicine enter the bloodstream.
This means the tablet needs to be taken carefully.
You should take it on an empty stomach after fasting for at least 8 hours. Swallow the tablet whole with a small amount of plain water, up to 120 ml. You then need to wait at least 30 minutes before eating, drinking or taking other oral medicines.
It can take a little planning, especially if you normally take several medicines in the morning. Your prescriber or pharmacist can advise you if you are unsure about how to fit the tablet around your other medicines.
Foundayo: a different type of oral GLP1 medicine
Foundayo contains orforglipron, a non peptide GLP1 receptor agonist.
Unlike oral semaglutide, it does not need to be taken on an empty stomach. The UK product information states that it can be taken once a day at any time, without food or water restrictions.
That does not mean there are no instructions to follow. Foundayo tablets should be swallowed whole and should not be broken, crushed or chewed. The dose is also increased gradually, with changes based on treatment response and tolerability.
Comparing the Oral Options
| Wegovy Pill (Semaglutide) | Foundayo (Orforglipron) | |
|---|---|---|
| Active ingredient | Semaglutide | Orforglipron |
| Type of medicine | Peptide GLP1 receptor agonist | Non peptide GLP1 receptor agonist |
| How often it is taken | Once daily | Once daily |
| Food and water instructions | Empty stomach, small amount of water, then wait at least 30 minutes | No specific food or water restriction |
| Dose increases | 1.5 mg, 4 mg, 9 mg and 25 mg | 0.8 mg, 2.5 mg, 5.5 mg, 9 mg, 14.5 mg and 17.2 mg |
| Weight management trial data | 16.6% average weight loss at 64 weeks in one clinical trial when treatment adherence was assumed | 12.4% average weight loss at 72 weeks with the 36 mg study dose in ATTAIN 1 |
| UK status | Licensed for weight management | Licensed for weight management and type 2 diabetes |
The trial figures above come from different studies, with different participants, doses and study designs. They should not be used to decide that one medicine will work better for a particular person.
For example, the Wegovy Pill figure comes from a 64 week study of 307 adults with overweight or obesity who did not have diabetes. The Foundayo figure comes from the 72 week ATTAIN 1 study, which included adults with obesity or overweight and at least one weight related health condition, but without type 2 diabetes.
Clinical trial averages are useful for understanding how a medicine performed in a study. They are not a prediction of an individual's result.
Getting the Routine Right With Oral Semaglutide
The instructions for oral semaglutide can seem quite specific at first, but they are there for a reason.
The tablet should be taken after at least 8 hours of fasting, with no more than 120 ml of water. Once you have taken it, wait at least 30 minutes before having breakfast, drinking anything else or taking other oral medicines.
A simple routine can make this easier to remember. For example, some people may find it useful to take the tablet when they first wake up and then get ready for the day before having breakfast.
Do not change the instructions because they feel inconvenient. If the timing is difficult because you take other medicines in the morning, speak to your prescriber or pharmacist about what is appropriate for you.
Is an Oral or Injectable GLP1 Medicine Right for You?
For some people, the main appeal of an oral medicine is simple: there is no injection.
For others, taking a tablet every day may be less convenient than having a weekly injection. Oral semaglutide also comes with specific instructions around fasting, water and other medicines, while Foundayo does not have the same food and water restrictions.
There are other things to consider too. Your medical history, other medicines, treatment goals, possible side effects and any health conditions you have can all affect whether a particular medicine is suitable.
It is also important not to assume that a tablet will give the same result as an injection. Different medicines have been studied in different trials, so their results cannot always be compared directly.
If you are unsure which option might suit your circumstances, that is exactly the kind of question to raise during your clinical assessment.
Starting Oral GLP1 Treatment in the UK
What happens during an online consultation?
Starting treatment is not simply a case of choosing a tablet and placing an order.
You will usually need to provide information about your health, medical history, current medicines and, where relevant, your weight and BMI. You may also be asked about health conditions such as high blood pressure, type 2 diabetes or other weight related conditions.
A UK registered prescriber reviews this information to decide whether treatment is clinically appropriate. They may ask for further information if something in your medical history needs clarification.
If treatment is suitable, you should also receive information about how to take the medicine, possible side effects and when to seek further medical advice.
How much does an oral GLP1 medicine cost?
The price depends on the medicine, strength and provider. Prices can also change, so it is best to check the current product page before ordering.
At the time of writing, entry level treatment starts from around £109.99. The live product page should always be checked for the current price and any applicable treatment or consultation fees.
Safety Considerations
GLP1 medicines are prescription medicines and are not suitable for everyone. Your prescriber should consider your medical history, other medicines and any relevant health conditions before treatment is supplied.
Digestive side effects are common with GLP1 medicines. These can include nausea, vomiting, diarrhoea, constipation and abdominal discomfort. Side effects can vary from person to person and may change as the dose is increased.
There are also specific warnings and precautions for these medicines. For example, semaglutide has been associated with acute pancreatitis, and people with a history of pancreatitis need individual medical advice before treatment. Severe gastrointestinal symptoms can also lead to dehydration.
If you develop severe or persistent symptoms while taking a GLP1 medicine, contact your healthcare professional. Seek urgent medical attention for symptoms that could indicate a serious reaction, such as severe and persistent abdominal pain.
Always follow the patient information leaflet supplied with your medicine and the advice given by your prescriber.
Medical Disclaimer
This content is provided for general information only and does not replace medical advice, diagnosis or treatment from a qualified healthcare professional.
GLP1 medicines are prescription medicines and are not suitable for everyone. Whether treatment is appropriate depends on your individual circumstances and a clinical assessment by a UK registered prescriber.
The information on this page is intended to help you understand the options available. It should not be used to start, stop or change a medicine without speaking to a healthcare professional.
Frequently Asked Questions
Is there a GLP1 pill available in the UK?
Yes. There are now oral GLP1 medicines available in the UK.
Wegovy Pill and Foundayo are licensed for weight management in eligible adults. Rybelsus is an oral semaglutide medicine licensed for type 2 diabetes.
If you are looking specifically for an oral option for weight management, a prescriber will need to check whether you meet the relevant eligibility criteria and whether the medicine is suitable for you.
What oral GLP1 medicines are licensed in the UK?
There are currently three oral GLP1 medicines to know about: Wegovy Pill, Foundayo and Rybelsus.
Wegovy Pill contains semaglutide and is licensed for weight management. Foundayo contains orforglipron and is licensed for weight management and type 2 diabetes. Rybelsus also contains semaglutide but is licensed for type 2 diabetes.
The fact that two medicines contain the same active ingredient does not mean they have the same licence or should be used in the same way.
What is the best GLP1 tablet for weight loss?
There is no single tablet that is right for everyone.
Wegovy Pill and Foundayo contain different active ingredients and have different dosing instructions. Your medical history, other medicines, treatment needs and preferences all need to be considered before a prescriber recommends a treatment.
Clinical trial results can provide useful information about how each medicine performed in a study, but they cannot tell you exactly which medicine will work best for you.
How is a GLP1 tablet different from an injection?
The main difference is how the medicine gets into your body.
An injection delivers the medicine directly into the body without having to pass through the digestive system. Oral medicines have to be designed to work after being swallowed.
Wegovy Pill uses an absorption enhancer to help semaglutide get absorbed in the stomach. Foundayo uses orforglipron, a non peptide molecule that does not need the same approach.
There can also be practical differences. Oral medicines are taken daily, while some injectable GLP1 medicines are taken weekly.
Why does oral semaglutide need to be taken on an empty stomach?
It is mainly about absorption.
Oral semaglutide is absorbed in the stomach, and its absorption can be reduced by food or larger amounts of water. Taking it after fasting, with a small amount of water, and waiting at least 30 minutes before eating, drinking or taking other oral medicines helps follow the way the medicine was designed to be taken.
If you take other medicines in the morning, ask your prescriber or pharmacist how to fit them around your semaglutide tablet.
Does Foundayo have food or water restrictions?
No specific food or water restriction applies to Foundayo.
The UK product information says that Foundayo can be taken once a day at any time, without food or water restrictions. The tablet should still be swallowed whole and should not be broken, crushed or chewed.
Is Wegovy Pill the same as Ozempic in tablet form?
No.
Wegovy Pill and Ozempic both contain semaglutide, but they are different products with different licences and routes of administration.
Wegovy Pill is the oral semaglutide product licensed for weight management. Ozempic is an injectable semaglutide medicine licensed for type 2 diabetes.
Rybelsus is the oral semaglutide medicine licensed for type 2 diabetes.
What is the difference between Wegovy Pill and Foundayo?
The biggest difference is the active ingredient.
Wegovy Pill contains semaglutide, while Foundayo contains orforglipron. They also have different chemical structures and different instructions for taking them.
Wegovy Pill needs to be taken on an empty stomach with a small amount of water, followed by a wait of at least 30 minutes. Foundayo can be taken once a day at any time without specific food or water restrictions.
They have also been studied in different clinical trials, so their trial results should not be treated as a direct head to head comparison.
Is oral semaglutide as effective as the injection?
There is no simple way to answer this by comparing percentages from different studies.
Oral and injectable semaglutide have been studied in different clinical trials, involving different groups of people and different treatment schedules. The results can therefore give useful context, but they do not provide a direct head to head comparison.
Your prescriber can help you understand which formulation is appropriate based on your circumstances.
How much weight can I lose with an oral GLP1 medicine?
There is no guaranteed amount of weight loss.
In clinical trials, average results differed between medicines and studies. For example, oral semaglutide 25 mg was associated with an average 16.6% reduction in body weight at 64 weeks in one analysis of the OASIS 4 study. In the ATTAIN 1 study, the 36 mg orforglipron group had an average 12.4% reduction at 72 weeks.
These are study averages, not personal predictions. Your result can be different depending on factors such as your health, treatment response, dose and how long you take the medicine.
Is Rybelsus available for weight loss?
Rybelsus is licensed in the UK for the treatment of type 2 diabetes, rather than specifically for weight management.
Although Rybelsus contains semaglutide, it should not simply be treated as the tablet version of Wegovy Pill. They have different licences and approved uses.
If you are looking for treatment for weight management, speak to a prescriber about the medicines that are specifically licensed for that purpose.
Should I choose a GLP1 tablet or an injection?
That depends on your circumstances and what you can comfortably manage as part of your treatment.
A tablet may appeal if you would rather not have injections. On the other hand, daily tablets can require more regular dosing, and oral semaglutide has specific instructions around fasting, water and other medicines.
Your medical history and any medicines you already take are also important. A clinical assessment can help you understand which options are suitable for you and why.
Can I switch from an injection to a GLP1 tablet?
Sometimes a switch may be possible, but it should be discussed with your prescriber rather than done yourself.
The timing and dose can depend on which medicine you are currently taking. For example, the UK prescribing information for oral Wegovy includes specific instructions for people switching from weekly semaglutide injections.
Do not take an oral and injectable GLP1 medicine together unless your prescriber has specifically told you to do so.
How do I start treatment with an oral GLP1 medicine in the UK?
You can start by speaking with a GP, pharmacist or another appropriate prescriber, or by using a regulated online service that offers a clinical assessment.
You will normally be asked about your medical history, current medicines, weight and BMI, along with any relevant health conditions.
A UK registered prescriber will then review the information and decide whether an oral GLP1 medicine is appropriate for you. If it is, they can explain how to take it, what side effects to look out for and what follow up support you may need.
How Weight Loss Injections Work in the UK: BMI & Eligibility Guide
Realistic Fast Weight Loss in the UK: What to Expect and Avoid
Related Posts
Protecting Muscle During Rapid Weight Loss
Compounded Tirzepatide: What Is Actually In It?
Beyond the Scale: Weight Loss and Organ Health
Ozempic or Mounjaro? What Applies in the UK
